Tomoko Tadokoro

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

Koji Fujita, Kyoko Oura, Hirohito Yoneyama et al. · Hepatology Research · 2019 · 65 citations · Full text

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study

Joji Tani, Asahiro Morishita, Teppei Sakamoto et al. · Oncology Letters · 2020 · 55 citations · Full text

Hepatitis B, Pathology, Daa Treatment +25

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest

Eri Samukawa, Shintaro Fujihara, Kyoko Oura et al. · International Journal of Oncology · 2017 · 49 citations · Full text

Hucct-1 Cells, Immunology, Pathology +17

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Kyoko Oura, Tomoko Tadokoro, Shintaro Fujihara et al. · Oncology Reports · 2017 · 48 citations · Full text

Telmisartan Treatment, Immunology, Tumor Biology +18

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway<i>in vitro</i>and<i>in vivo</i>

Shintaro Fujihara, Asahiro Morishita, Kana Ogawa et al. · Oncotarget · 2016 · 38 citations · Full text

Tumor Biology, Esophageal Cancer, Chemoprevention Strategy +14